Grape King Bio Ltd

Grape King Bio Ltd

Share · TW0001707008 (XTAI)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Grape King Bio Ltd
No Price
Closing Price XTAI 29.04.2026: 114,00 TWD
29.04.2026 05:30
Current Prices from Grape King Bio Ltd
ExchangeTickerCurrencyLast TradePriceDaily Change
XTAI: TWSE
TWSE
1707.TW
TWD
29.04.2026 05:30
114,00 TWD
0,00 TWD
Share Float & Liquidity
Free Float 78,18 %
Shares Float 115,82 M
Shares Outstanding 148,14 M
Invested Funds

The following funds have invested in Grape King Bio Ltd:

Fund
iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF USD (Dist)
Vol. in million
98,34
Percentage (%)
0,10 %
Fund
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Dist)
Vol. in million
18,58
Percentage (%)
0,006 %
Fund
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Acc)
Vol. in million
94,06
Percentage (%)
0,006 %
Company Profile for Grape King Bio Ltd Share
Grape King Bio Ltd produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy foods in Taiwan, China, and internationally. It operates through Multi-Level Marketing, Distributors, and Original Design Manufacturer/Original Equipment Manufacturer (ODM/OEM) segments. The company offers mushroom mycelium products, such as ganoderma lucidum, agaricus blazei, antrodia cinnamomea, cordyceps sinensis, and coriolus versicolor; probiotics, including enterococcus, bifidobacterium, lactobacillus, pediococcus, streptococcus, saccharomyces, and clostridium; and enzymes. It also provides OEM, ODM, formulation design, research and development, and raw material supply services. The company was founded in 1969 and is headquartered in Taoyuan City, Taiwan.

Company Data

Name Grape King Bio Ltd
Company Grape King Bio Ltd
Website https://www.grapeking.com.tw
Primary Exchange XTAI TWSE
ISIN TW0001707008
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Sheng-Lin Tseng
Market Capitalization 17 Mrd.
Country Taiwan
Currency TWD
Employees 0,5 T
Address Jinling Road, 324 Taoyuan City
IPO Date 2000-01-04
Dividends from 'Grape King Bio Ltd'
Ex-Date Dividend per Share
08.01.2026 2,20 TWD
23.06.2025 4,20 TWD
21.01.2025 2,70 TWD
20.06.2024 6,90 TWD
20.06.2023 6,90 TWD
15.06.2022 6,10 TWD
02.08.2021 6,40 TWD
24.06.2020 6,50 TWD
24.06.2019 6,50 TWD
09.07.2018 6,68 TWD

Stock Splits

Date Split
15.09.2005 51:50

Ticker Symbols

Name Symbol
TWSE 1707.TW
More Shares
Investors who hold Grape King Bio Ltd also have the following shares in their portfolio:
DZ BANK      IS.A2113
DZ BANK IS.A2113 Bond
Hiecise Precision Equipment Co.,Ltd.
Hiecise Precision Equipment Co.,Ltd. Share